News & events

Upcoming events

See all upcoming events

Latest news

Fujirebio Europe releases the Lumipulse® G HE4 assay dedicated to ovarian cancer therapy monitoring and as an aid in estimating the risk of epithelial ovarian cancer in women with pelvic mass

Fujirebio Europe today announced the release of its new Lumipulse G HE4 assay which will be available for testing on its CLEIA-based LUMIPULSE G systems, the LUMIPULSE G600II and the LUMIPULSE G1200. Lumipulse G HE4 is the first new biomarker for ovarian cancer management in more than 30 years1 after the initial launch by Fujirebio of the CA125 test (also available on the LUMIPULSE G series).

Read more

Fujirebio Europe upgrades its HPV (Human Papillomavirus) genotyping panel with the launch of the INNO-LiPA® HPV Genotyping Extra II assay

Fujirebio Europe today announced the release of the INNO-LiPA® HPV Genotyping Extra II assay for HPV type-specific patient monitoring and cervical cancer management. This CE-marked strip-based assay is available for automated testing on the Auto-LiPA™ 48 and AutoBlot 3000H platforms and the upcoming TENDIGO™ platform as well as for manual testing.

Read more

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.